Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Merrilee Needham & Frank Mastaglia. (2017) Advances in inclusion body myositis: genetics, pathogenesis and clinical aspects. Expert Opinion on Orphan Drugs 5:5, pages 431-443.
Read now
Read now
M. Kusaoi, T. Fukazawa, M. Hirashima, Y. Morita, C. Yamaji, S. Takai, Y. Takasaki & H. Hashimoto. (2003) A case of inclusion body myositis with systemic sclerosis. Modern Rheumatology 13:1, pages 87-89.
Read now
Read now
Articles from other publishers (41)
D. De Biase, A. Costagliola, T.B. Pagano, G. Piegari, S. Wojcik, J. Dziewiątkowski, E. Grieco, G. Mattace Raso, V. Russo, S. Papparella & O. Paciello. (2017) Amyloid precursor protein, lipofuscin accumulation and expression of autophagy markers in aged bovine brain. BMC Veterinary Research 13:1.
Crossref
Crossref
Mercedes Arnés, Sergio Casas-Tintó, Anders Malmendal & Alberto Ferrús. (2017)
Amyloid β42 peptide is toxic to non-neural cells in
Drosophila
yielding a characteristic metabolite profile and the effect can be suppressed by PI3K
. Biology Open 6:11, pages 1664-1671.
Crossref
Crossref
Masahiro Nakamori, Tetsuya Takahashi, Tomokazu Nishikawa, Yu Yamazaki, Takashi Kurashige, Hirofumi Maruyama, Koji Arihiro & Masayasu Matsumoto. (2013) Molecular Markers for Granulovacuolar Degeneration Are Present in Rimmed Vacuoles. PLoS ONE 8:11, pages e80995.
Crossref
Crossref
Danijela Levacic, Leema Reddy Peddareddygari, David Nochlin, Leroy R. Sharer & Raji P. Grewal. (2013) Inclusion-Body Myositis Associated with Alzheimer’s Disease. Case Reports in Medicine 2013, pages 1-3.
Crossref
Crossref
Marianne Eriksson & Christopher Lindberg. (2012) Hand Function in 45 Patients with Sporadic Inclusion Body Myositis. Occupational Therapy International 19:2, pages 108-116.
Crossref
Crossref
C. Lindberg & A. Oldfors. (2012) Prognosis and prognostic factors in sporadic inclusion body myositis. Acta Neurologica Scandinavica 125:5, pages 353-358.
Crossref
Crossref
R. Mathew, G. Srinivas & P.S. Mathuranath. 2011. Neurochemical Mechanisms in Disease. Neurochemical Mechanisms in Disease
633
667
.
Alexander Shtifman, Christopher W. Ward, Derek R. Laver, Mark L. Bannister, Jose R. Lopez, Masashi Kitazawa, Frank M. LaFerla, Noriaki Ikemoto & Henry W. Querfurth. (2010) Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle. Neurobiology of Aging 31:12, pages 2080-2090.
Crossref
Crossref
Ingrid E. Lundberg & Li Alemo Munters. 2010. Muscle Pain: Diagnosis and Treatment. Muscle Pain: Diagnosis and Treatment
229
246
.
Murali Jayaraman, Gomathi Kannayiram & Jayakumar Rajadas. (2008) Amyloid toxicity in skeletal myoblasts: Implications for inclusion-body myositis. Archives of Biochemistry and Biophysics 474:1, pages 15-21.
Crossref
Crossref
Virginia. E. Kimonis, Sarju G. Mehta, Erin C. Fulchiero, Dana Thomasova, Marzia Pasquali, Kym Boycott, Edward G. Neilan, Alex Kartashov, Mark S. Forman, Stuart Tucker, Katerina Kimonis, Steven Mumm, Michael P. Whyte, Charles D. Smith & Giles D. J. Watts. (2008) Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. American Journal of Medical Genetics Part A 146A:6, pages 745-757.
Crossref
Crossref
Merrilee Needham, Amanda Hooper, Ian James, Frank van Bockxmeer, Alastair Corbett, Timothy Day, Michael J. Garlepp & Frank L. Mastaglia. (2008) Apolipoprotein ε alleles in sporadic inclusion body myositis: A reappraisal. Neuromuscular Disorders 18:2, pages 150-152.
Crossref
Crossref
Merrilee Needham & Frank L Mastaglia. (2007) Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. The Lancet Neurology 6:7, pages 620-631.
Crossref
Crossref
Piraye Serdaroglu. 2007. Myopathies. Myopathies
357
388
.
Anna Fidziańska & Zofia Glinka. (2006) Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy. Acta Neuropathologica 112:2, pages 185-193.
Crossref
Crossref
Michael C. Sugarman, Masashi Kitazawa, Michael Baker, Vincent J. Caiozzo, Henry W. Querfurth & Frank M. LaFerla. (2006) Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model. Neurobiology of Aging 27:3, pages 423-432.
Crossref
Crossref
Joel N. Buxbaum. (2006) Treatment and prevention of the amyloidoses. Neurology 66:1_suppl_1.
Crossref
Crossref
M. Paul MurphyTodd E. Golde. (2006) Inclusion-body myositis and Alzheimer disease. Neurology 66:1_suppl_1.
Crossref
Crossref
Valerie Askanas & W. King Engel. (2005) Molecular pathology and pathogenesis of inclusion-body myositis. Microscopy Research and Technique 67:3-4, pages 114-120.
Crossref
Crossref
Massimo Stefani. (2004) Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1739:1, pages 5-25.
Crossref
Crossref
Rabi Tawil & Robert C. Griggs. (2002) Inclusion body myositis. Current Opinion in Rheumatology 14:6, pages 653-657.
Crossref
Crossref
S. B. RutkoveR. A. ParkerR. A. NardinC. E. ConnollyK. J. FeliceE. M. Raynor. (2002) A pilot randomized trial of oxandrolone in inclusion body myositis. Neurology 58:7, pages 1081-1087.
Crossref
Crossref
Umesh A. Badrising, Marion L.C. Maat‐Schieman, Michel D. Ferrari, Aeilko H. Zwinderman, Judith A.M. Wessels, Ferdinand C. Breedveld, Pieter A. van Doorn, Baziel G.M. van Engelen, Jessica E. Hoogendijk, Chris J. Höweler, Aeiko E. de Jager, Frans G.I. Jennekens, Peter J. Koehler, Marianne de Visser, Alain Viddeleer, Jan J. Verschuuren & Axel R. Wintzen. (2002) Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo. Annals of Neurology 51:3, pages 369-372.
Crossref
Crossref
Margaret J. Kovach, Brook Waggoner, Suzanne M. Leal, David Gelber, Romesh Khardori, Mark A. Levenstien, Christy A. Shanks, Gregory Gregg, Muhammad T. Al-Lozi, Timothy Miller, Wojtek Rakowicz, Glenn Lopate, Juliane Florence, Guila Glosser, Zachary Simmons, John C. Morris, Michael P. Whyte, Alan Pestronk & Virginia E. Kimonis. (2001) Clinical Delineation and Localization to Chromosome 9p13.3–p12 of a Unique Dominant Disorder in Four Families: Hereditary Inclusion Body Myopathy, Paget Disease of Bone, and Frontotemporal Dementia. Molecular Genetics and Metabolism 74:4, pages 458-475.
Crossref
Crossref
Henry J Kaminski & Francisco H Andrade. (2001) Nitric oxide: biologic effects on muscle and role in muscle diseases. Neuromuscular Disorders 11:6-7, pages 517-524.
Crossref
Crossref
S. Arnardottir, T. Ansved, I. Nennesmo & K. Borg. (2001)
Report of a patient with inclusion body myositis and CD8
+
chronic lymphocytic leukaemia - post-mortem analysis
of muscle and brain
. Acta Neurologica Scandinavica 103:2, pages 131-135.
Crossref
Crossref
Johannes B. Lampe, Maggie C. Walter & Heinz Reichmann. 2001. Neuropathology and Genetics of Dementia. Neuropathology and Genetics of Dementia
219
228
.
Ejaz A. Shamim, Lisa G. Rider & Frederick W. Miller. (2000) Update on the genetics of the idiopathic inflammatory myopathies. Current Opinion in Rheumatology 12:6, pages 482-491.
Crossref
Crossref
Grzegorz M Wilczynski, W.King Engel & Valerie Askanas. (2000) Cyclin-dependent kinase 5 colocalizes with phosphorylated tau in human inclusion-body myositis paired-helical filaments and may play a role in tau phosphorylation. Neuroscience Letters 293:1, pages 33-36.
Crossref
Crossref
Kenneth S. O'Rourke. (2000) MYOPATHIES IN THE ELDERLY. Rheumatic Disease Clinics of North America 26:3, pages 647-672.
Crossref
Crossref
Aldobrando Broccolini, W.King Engel, Renate B Alvarez & Valerie Askanas. (2000) Redox factor-1 in muscle biopsies of patients with inclusion-body myositis. Neuroscience Letters 287:1, pages 1-4.
Crossref
Crossref
Grzegorz M. Wilczynski, W. King Engel & Valerie Askanas. (2000) Association of Active Extracellular Signal-Regulated Protein Kinase with Paired Helical Filaments of Inclusion-Body Myositis Muscle Suggests Its Role in Inclusion-Body Myositis Tau Phosphorylation. The American Journal of Pathology 156:6, pages 1835-1840.
Crossref
Crossref
Aldobrando Broccolini, W. King Engel, Renate B. Alvarez & Valerie Askanas. (2000) Paired Helical Filaments of Inclusion-Body Myositis Muscle Contain RNA and Survival Motor Neuron Protein. The American Journal of Pathology 156:4, pages 1151-1155.
Crossref
Crossref
Valerie Askanas, W. King Engel, Renate B. Alvarez, Blas Frangione, Jorge Ghiso & Ruben Vidal. (2000) Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele. Annals of Neurology 47:4, pages 544-549.
Crossref
Crossref
Brenda L. BanwellAndrew G. Engel. (2000) αB-Crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 54:5, pages 1033-1041.
Crossref
Crossref
George KarpatiReinhard Hohlfeld. (2000) Biologically stressed muscle fibers in sporadic IBM. Neurology 54:5, pages 1020-1021.
Crossref
Crossref
Yu-Min Kuo, Tyler A. Kokjohn, M. Desiree Watson, Amina S. Woods, Robert J. Cotter, Lucia I. Sue, Walter M. Kalback, Mark R. Emmerling, Thomas G. Beach & Alex E. Roher. (2000) Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP Metabolism. The American Journal of Pathology 156:3, pages 797-805.
Crossref
Crossref
Anders Oldfors & Christopher Lindberg. (1999) Inclusion body myositis. Current Opinion in Neurology 12:5, pages 527-533.
Crossref
Crossref
K. Sathasivam, C. Hobbs, M. Turmaine, L. Mangiarini, A. Mahal, F. Bertaux, E. E. Wanker, P. Doherty, S. W. Davies & G. P. Bates. (1999) Formation of Polyglutamine Inclusions in Non-CNS Tissue. Human Molecular Genetics 8:5, pages 813-822.
Crossref
Crossref
Tommy Martinsson, Niklas Darin, Mårten Kyllerman, Anders Oldfors, Birgitta Hallberg & Jan Wahlström. (1999) Dominant Hereditary Inclusion-Body Myopathy Gene (IBM3) Maps to Chromosome Region 17p13.1. The American Journal of Human Genetics 64:5, pages 1420-1426.
Crossref
Crossref
Jean Amiral. (1999) Diagnostic Approach of Phospholipid-Dependent Antibodies. Pathophysiology of Haemostasis and Thrombosis 29:2-3, pages 135-149.
Crossref
Crossref